CBS News
Full transcript of Face the Nation on May 2, 2021
Ronald Klain, White House Chief of Staff
Sen. Tim Scott, R- South Carolina
Dr. Scott Gottlieb, Former FDA Commissioner
Click here to browse full transcripts of Face the Nation.
JOHN DICKERSON: I m John Dickerson in Washington. And this week on FACE THE NATION, we ll talk exclusively with two key players in the drama that s likely to impact every American. President Biden is pitching the most ambitious and most expensive set of domestic reforms in decades. Together his proposals total more than six trillion dollars in new spending. Do we need it all, and how are we going to pay for it?
UW looking for healthy volunteers for second-generation COVID-19 vaccine clinical trial Deborah Horne
The University of Washington Medicine is looking for healthy volunteers who have not yet been vaccinated against the coronavirus vaccine.
The university hopes they’ll participate in a clinical trial to develop a brand-new vaccine.
Vaccines are already being given out at Lumen Field and across the state.
These scientists now want to create a vaccine that could be even more effective than those already in circulation.
It is a race against time. As the country ramps up efforts to get as many Americans vaccinated as possible, some scientists are hoping to find a willing few who are not yet vaccinated.
Initial trial of Moderna s COVID-19 vaccine began one year ago wesh.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wesh.com Daily Mail and Mail on Sunday newspapers.
Initial trial of Moderna s COVID-19 vaccine began one year ago Share Updated: 5:57 AM EDT Mar 16, 2021
Initial trial of Moderna s COVID-19 vaccine began one year ago Share Updated: 5:57 AM EDT Mar 16, 2021
Hide Transcript
TRACKING THE COVID-19 VACCINE Share Updated: 5:57 AM EDT Mar 16, 2021 One year ago, on the same day that Massachusetts schools were ordered to close because of the COVID-19 pandemic, a local company began the first phase of testing a coronavirus vaccine.The vaccine from Cambridge-based Moderna was given to the first of 45 participants in the Phase 1 trial on March 16, 2020. The testing that would ultimately lead to authorization of the vaccine began with a careful jab at the Kaiser Permanente Washington Research Institute in Seattle.The first patient was Jennifer Haller, a mother of two. “We all feel so helpless. This is an amazing opportunity for me to do something,” she said at the time.The vaccine was created based on